KPIs & Operating Metrics(New)

Gsk (GSK) Cash & Equivalents Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.69%
Dec 31, 2025 -11.47%
Sep 30, 2025 -15.52%
Jun 30, 2025 -13.89%
Mar 31, 2025 -1.66%
Dec 31, 2024 -3.87%
Sep 30, 2024 -4.82%
Jun 30, 2024 -6.75%
Mar 31, 2024 -8.03%
Dec 31, 2023 -6.07%
Sep 30, 2023 -4.03%
Jun 30, 2023 -6.55%
Mar 31, 2023 -8.81%
Dec 31, 2022 -3.01%
Sep 30, 2022 -7.29%
Jun 30, 2022 9.83%
Mar 31, 2022 21.38%
Dec 31, 2021 -1.10%
Sep 30, 2021 -4.73%
Jun 30, 2021 -5.77%
Mar 31, 2021 -2.44%
Dec 31, 2020 -1.25%
Sep 28, 2020 -1.17%
Jun 30, 2020 -3.52%
Mar 31, 2020 -17.09%
Dec 31, 2019 -2.51%
Sep 30, 2019 -5.00%
Jun 30, 2019 -0.07%
Mar 31, 2019 -1.55%
Dec 31, 2018 -11.07%
Sep 30, 2018 -0.39%
Jun 30, 2018 4.79%
Mar 31, 2018 -1.34%
Dec 31, 2017 -76.02%
Sep 30, 2017 3.00%
Jun 30, 2017 -15.32%
Mar 31, 2017 -8.80%
Dec 31, 2016 -78.27%
Sep 30, 2016 -7.00%
Jun 30, 2016 -7.11%
Mar 31, 2016 -6.53%
Dec 31, 2015 -1.56%
Sep 30, 2015 2.57%
Jun 30, 2015 4.33%
Mar 31, 2015 7.50%
Dec 31, 2014 -8.46%
Sep 30, 2014 -8.35%
Jun 30, 2014 -8.46%
Mar 31, 2014 -8.24%